Rheumatoid vasculitis
Systemic small-medium vessel vasculitis · Rheumatology
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
A severe extra-articular complication of longstanding seropositive rheumatoid arthritis causing necrotising vasculitis of small and medium vessels. It presents with cutaneous ulcers, nailfold infarcts, mononeuritis multiplex, digital gangrene and occasionally visceral or coronary involvement.
Red flags
- Mononeuritis multiplex (foot/wrist drop)
- Digital gangrene or progressive ulceration
- Mesenteric angina or GI bleeding (visceral vasculitis)
- Scleritis or retinal vasculitis with visual loss
- Coronary involvement with chest pain
Assessment
Differential diagnosis
- ANCA-associated vasculitis
- Cryoglobulinaemic vasculitis
- Infective endocarditis with emboli
- Cholesterol embolisation
- Antiphospholipid syndrome
- Diabetic / atherosclerotic peripheral vascular disease
Investigations
- RF (usually high titre), anti-CCP, ANA, ANCA, cryoglobulins
- Complement (C3/C4 often low), CRP, ESR
- Skin / sural nerve biopsy for necrotising vasculitis
- Nerve conduction studies if mononeuritis multiplex
- Echocardiogram and blood cultures to exclude endocarditis
- Urinalysis and renal function for visceral involvement
Management
- Assess extent: skin, digits, peripheral nerves, eyes, gut, heart and kidneys
- Exclude infection (especially endocarditis) before immunosuppression
- Confirm with biopsy where feasible (skin or nerve)
- Grade severity: isolated nailfold lesions may be managed conservatively; systemic/organ-threatening disease needs aggressive therapy
- Start high-dose corticosteroid for active systemic vasculitis
- Add cyclophosphamide or rituximab for organ-threatening disease
- Optimise RA disease control and stop smoking; manage digital ischaemia with vasodilators
- Monitor for treatment-related infection and cytopenia
Drugs & doses
Prednisolone — 1 mg/kg/day PO (up to 60 mg) for systemic disease
Methylprednisolone — 500 mg-1 g IV OD x3 for organ-threatening vasculitis
Cyclophosphamide — 15 mg/kg IV every 2-3 weeks (reduce for age/renal function)
Rituximab — 1 g IV on days 1 and 15
Iloprost — IV infusion for critical digital ischaemia per local protocol
Disposition
Admit for systemic/organ-threatening disease; urgent rheumatology input and immunosuppression after excluding infection.
Complications & pitfalls
- Digital/limb amputation
- Permanent peripheral nerve damage
- Bowel infarction
- Myocardial infarction
- Immunosuppression-related sepsis
Exam pearls
- Occurs in longstanding, erosive, high-titre seropositive RA, often as articular disease 'burns out'
- Nailfold and digital pulp infarcts (Bywaters lesions) are an early sign
- Always exclude endocarditis - it mimics vasculitis and contraindicates immunosuppression
- Smoking strongly associated
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.